X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (14) 14
neurosciences (12) 12
agonist-induced rotation (9) 9
humans (9) 9
rats (7) 7
male (6) 6
messenger-rna (6) 6
metabotropic glutamate receptors (6) 6
parkinson's disease (6) 6
rats, sprague-dawley (6) 6
basal ganglia (5) 5
dopamine (5) 5
subthalamic nucleus (5) 5
agonist-induced desensitization (4) 4
biochemistry & molecular biology (4) 4
dopamine agonists - pharmacology (4) 4
dose-response relationship, drug (4) 4
index medicus (4) 4
parkinson disease - drug therapy (4) 4
parkinson disease - physiopathology (4) 4
pharmacology & pharmacy (4) 4
agonist-induced phosphorylation (3) 3
article (3) 3
basal ganglia - metabolism (3) 3
neostriatum - metabolism (3) 3
parkinson disease - metabolism (3) 3
parkinsons-disease (3) 3
protein-coupled receptor (3) 3
substantia-nigra (3) 3
amino acids (2) 2
amino acids, dicarboxylic - pharmacology (2) 2
apomorphine - pharmacology (2) 2
arrestins - metabolism (2) 2
autoradiography (2) 2
basal ganglia - anatomy & histology (2) 2
basal ganglia - drug effects (2) 2
basal ganglia - physiology (2) 2
basal ganglia - physiopathology (2) 2
behavior, animal (2) 2
biomedicine (2) 2
blotting, western - methods (2) 2
brain - drug effects (2) 2
brain - metabolism (2) 2
brain - physiopathology (2) 2
clinical neurology (2) 2
corpus striatum - metabolism (2) 2
d-1 (2) 2
delta-opioid receptor (2) 2
disease models, animal (2) 2
dopamine - metabolism (2) 2
dopamine agonists - administration & dosage (2) 2
dopamine neurons (2) 2
dopamine receptors (2) 2
follicle stimulating hormone - metabolism (2) 2
follicle-stimulating-hormone (2) 2
functional-anatomy (2) 2
glucose - metabolism (2) 2
immunohistochemical localization (2) 2
immunohistochemistry (2) 2
immunoprecipitation - methods (2) 2
in-vivo (2) 2
internalization (2) 2
levodopa - therapeutic use (2) 2
localization (2) 2
methyl-d-aspartate (2) 2
motor activity - drug effects (2) 2
movement disorders (2) 2
movement-disorders (2) 2
neostriatum - drug effects (2) 2
neuronal-activity (2) 2
neurons (2) 2
neurons - metabolism (2) 2
nigra pars reticulata (2) 2
oxidopamine (2) 2
parkinson disease, secondary - physiopathology (2) 2
parkinsons disease (2) 2
pharmacology/toxicology (2) 2
phosphorylation (2) 2
protein-coupled receptors (2) 2
proto-oncogene proteins c-fos - metabolism (2) 2
psychiatry (2) 2
rat (2) 2
receptors, dopamine d1 - metabolism (2) 2
receptors, fsh - genetics (2) 2
receptors, fsh - metabolism (2) 2
receptors, metabotropic glutamate - agonists (2) 2
receptors, metabotropic glutamate - metabolism (2) 2
receptors, metabotropic glutamate - physiology (2) 2
rodents (2) 2
rotation (2) 2
striatum (2) 2
substantia nigra - metabolism (2) 2
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mptp (1) 1
2nd extracellular loop (1) 1
3rd extracellular loop (1) 1
3rd intracellular loop (1) 1
3rd transmembrane domain (1) 1
4-aminopyridine - pharmacology (1) 1
4th cytoplasmic loop (1) 1
5-ht (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Reviews Neuroscience, ISSN 1471-003X, 10/2005, Volume 6, Issue 10, pp. 787 - 798
Journal Article
Progress in Neurobiology, ISSN 0301-0082, 2000, Volume 62, Issue 1, pp. 63 - 88
Journal Article
Journal Article
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, ISSN 0028-1298, 03/2000, Volume 361, Issue 3, pp. 289 - 297
Motor function of group II metabotropic glutamate receptors was investigated by quantifying motor effects of bilateral infusions of the preferential group II... 
BASAL GANGLIA | amino acids | AGONIST-INDUCED ROTATION | DCG-IV | SPINAL-CORD | CATALEPSY | schizophrenia | IN-VIVO | NEURONS | PHARMACOLOGY & PHARMACY | motor behaviour | PERFORANT PATH | METHYL-D-ASPARTATE
Journal Article
Japanese Journal of Pharmacology, ISSN 0021-5198, 1998, Volume 77, Issue 3, pp. 227 - 233
The effects of talipexole on functional motor improvement in comparison with contraversive circling were studied in five chronic (5-7 years post MPTP-lesioned)... 
Journal Article
Journal Article
by Chin, S
[Hokkaido igaku zasshi] The Hokkaido journal of medical science, ISSN 0367-6102, 03/2000, Volume 75, Issue 2, p. 95
We have reported earlier that in alert cats the cerebellar flocculus contains many Purkinje cells that respond to pitch (vertical) rotation and that the... 
Cats | Ocular Motility Disorders - etiology | Consciousness | GABA Agonists | Cerebellum - drug effects | Cerebellum - physiology | Muscimol | Purkinje Cells - physiology | Animals | Ocular Motility Disorders - chemically induced | Photic Stimulation | Purkinje Cells - drug effects | Reflex, Vestibulo-Ocular
Journal Article
Psychopharmacology, ISSN 0033-3158, 6/2013, Volume 227, Issue 3, pp. 533 - 544
l-DOPA continues to be the primary treatment for patients with Parkinson’s disease; however, the benefits of long-term treatment are often accompanied by... 
Neurosciences | Rat | BMY-14802 | l -DOPA-induced dyskinesia | DA agonist-induced dyskinesia | 6-hydroxydopamine | Biomedicine | D 1 | D 2 | Pharmacology/Toxicology | Psychiatry | 5-HT 1A | Parkinson’s disease | Parkinson's disease | l-DOPA-induced dyskinesia | 5-HT | LEVODOPA-INDUCED DYSKINESIAS | PSYCHIATRY | D-2 | BEHAVIORAL SENSITIZATION | ANTIPSYCHOTIC AGENTS | D-1 | ABNORMAL INVOLUNTARY MOVEMENTS | 5-HT1A RECEPTOR STIMULATION | NEUROSCIENCES | 5-HT1A | PHARMACOLOGY & PHARMACY | DORSAL RAPHE NUCLEUS | L-DOPA-induced dyskinesia | MOTOR COMPLICATIONS | PARKINSONS-DISEASE | RODENT MODEL | Dyskinesia, Drug-Induced - etiology | Levodopa - therapeutic use | Pyrimidines - administration & dosage | Dopamine Agonists - therapeutic use | Motor Activity - drug effects | Rats | Male | Dopamine Agonists - adverse effects | Parkinson Disease - drug therapy | Pyrimidines - pharmacology | Antiparkinson Agents - adverse effects | Rats, Sprague-Dawley | Receptors, Dopamine D1 - metabolism | Antiparkinson Agents - therapeutic use | Animals | Levodopa - administration & dosage | Dyskinesia, Drug-Induced - drug therapy | Pyrimidines - therapeutic use | Levodopa - adverse effects | Dopamine Agonists - administration & dosage | Antiparkinson Agents - administration & dosage | Receptor, Serotonin, 5-HT1A - metabolism | Disease Models, Animal | Dopamine | Properties | Drug therapy | Dopa | Movement disorders | Side effects | Rodents | Parkinsons disease
Journal Article
PHYSIOLOGICAL REVIEWS, ISSN 0031-9333, 04/2007, Volume 87, Issue 2, pp. 565 - 592
The most prevalent physiological effects of ANG II, the main product of the renin-angiotensin system, are mediated by the AT(1) receptor, a rhodopsin-like... 
ANGSTROM CRYSTAL-STRUCTURE | GUINEA-PIG ILEUM | PHYSIOLOGY | 3RD TRANSMEMBRANE DOMAIN | AGONIST-INDUCED PHOSPHORYLATION | 4TH CYTOPLASMIC LOOP | PROTEIN-COUPLED RECEPTOR | 2ND EXTRACELLULAR LOOP | AMINO-ACID-RESIDUES | MEMBRANE-SPANNING SEGMENT | VASCULAR SMOOTH-MUSCLE | Rhodopsin | Research | Peptides | Structure | Angiotensin II receptor blockers
Journal Article